Daniel Tran, MD
Plastic and Reconstructive Surgery · Washington, DCNPI 1427080647
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (36.9%), food and beverage and education — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 70.3% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $1,433 and has fallen 95.4% since, to $66 in 2025.
Across 49 payments — averaging $67.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- Corcept Therapeutics$161
- Integra Lifesciences Corporation$158
- AbbVie$146
- Smith+Nephew$146
- Davol Inc.$100
- plus $267 from 8 others
What the payments were for
- Travel & lodging$1,21637%
- Food & beverage$1,07933%
- Education$1,00030%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 10 | $2,318 |
| Corcept Therapeutics | 8 | $161 |
| Integra Lifesciences Corporation | 7 | $158 |
| AbbVie(2 entities) | 2 | $146 |
| Smith+Nephew | 7 | $146 |
| Davol Inc. | 1 | $100 |
| Medtronic | 4 | $71 |
| Johnson & Johnson | 3 | $63 |
| Polynovo North America LLC | 1 | $29 |
| Tactile Systems Technology Inc | 2 | $28 |
| Acell, Inc. | 1 | $23 |
| TELA Bio, Inc. | 1 | $22 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Bolder Surgical LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$2,197
- DURYSTA$123
How this compares
Too few plastic and reconstructive surgery providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 12 | $148 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Washington
- David SongWashington$968K
- Troy PittmanWashington$153K
- Christopher AttingerWashington$30K
- Stephen BakerWashington$8K
- Steven DavisonWashington$7K
- Jerry ChaoWashington$3K
- Ivica DucicWashington$1K
- Paul MartinezWashington$835
- Michael BoyajianWashington$577
- Steven HoppingWashington$529
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.